- Medications and Glucose-6-Phosphate Dehydrogenase Deficiency An Evidence-Based Review
[作者:Youngster, I; Arcavi, L; Schechmaster, R; Akayzen, Y; Popliski, H; Shimonov, J; Beig, S; Berkovitch, M,期刊:Drug safety, 页码:713-726 , 文章类型: Review,,卷期:2010年33-9]
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect and one of the most common genetic disorders worldwide, with an estimated 400 million people worldwide carrying a mutation in the...
- Adverse Drug Reaction Reporting in the UK A Retrospective Observational Comparison of Yellow Card Reports Submitted by Patients and Healthcare Professionals
[作者:McLernon, DJ; Bond, CM; Hannaford, PC; Watson, MC; Lee, AJ; Hazell, L; Avery, A,期刊:Drug safety, 页码:775-788 , 文章类型: Article,,卷期:2010年33-9]
- Background: In the UK, spontaneous reporting of suspected adverse drug reactions (ADRs) by healthcare professionals has been in operation since 1964 through the Yellow Card Scheme (YCS) From 2005, patients themselves hav...
- Safety Profile of the Fluoroquinolones Analysis of Adverse Drug Reactions in Relation to Prescription Data Using Four Regional Pharmacovigilance Databases in Italy
[作者:Lapi, F; Tuccori, M; Motola, D; Pugi, A; Vietri, M; Montanaro, N; Vaccheri, A; Leoni, O; Cocci, A; Leone, R; Conforti, A; Moretti, U; Sessa, E; Mazzaglia, G; Mugelli, A; Mazzei, T; Vannacci, A,期刊:Drug safety, 页码:789-799 , 文章类型: Article,,卷期:2010年33-9]
- Background: Fluoroquinolones are widely used both in primary care and in hospital settings. Since the last comparison performed in Italy on the safety profiles of different fluoroquinolones, a new molecule, prulifloxacin...
|